Evidence map›Paper›PMID 39633115›Full record

ArticleApoptosis : an international journal on programmed cell death2025

Single-cell RNA sequencing analysis reveals the dynamic changes in the tumor microenvironment during NMIBC recurrence.

Ziang Chen, Tianxiang Zhang, Weijian Li, Jia Hu, Yuxi Ou, Fangdie Ye, Jinhao Zhang, Haowen Jiang, Shenghua Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Apoptosis : an international journal on programmed cell death, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Investigating the role of inflammatory bowel disease-associated gene expression in oral cancer using single-cell RNA sequencing.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ziang Chen *Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Tianxiang Zhang *Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Weijian Li *Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Jia HuDepartment of Anesthesiology, The Second Affiliated Hospital of Anhui Medical University, Anhui Medical University, Hefei, Anhui, China.
Yuxi OuDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Fangdie YeDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Jinhao ZhangDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Haowen JiangDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China. urology_hs@163.com.
Shenghua LiuDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China. liushenghuafy@163.com.

Funding

Clinical Scientific and Technological Innovation Project by Shanghai Hospital Development Center SHDC12021104Leading Talent Program by Shanghai Municipal Health Commission 2022LJ008Medical Innovation Research Special Project by Science and Technology Commission of Shanghai Municipality 22Y21900200National Natural Science Foundation of China 81802569
6 · The paper itself

Abstract

backgroundDue to the clinical characteristic of frequent recurrence in urothelial bladder cancer (UBC), patients face significant health impacts and economic burdens. Therefore, understanding the molecular mechanisms involved in UBC recurrence is crucial for reducing its recurrence rate. The aim of our study is to help urologists and clinical researchers gain a deeper understanding of the changes in the tumor microenvironment (TME) during UBC recurrence.

methodsWe collected 10 samples from primary and recurrent non-muscle-invasive bladder cancer (NMIBC) and performed single-cell RNA sequencing. By distinguishing and annotating cell subpopulations, we identified tissue preferences of some novel cell subgroups. Next, pseudotime trajectory analysis, cell-cell communication analysis, and function enrichment analysis were applied to evaluate the dynamic changes in the TME and biological functions. Finally, we validated the distribution of some of these cell subgroups using multiplex immunofluorescence experiments.

resultsWe identified a tumor-associated fibroblast (CAF) subtype with high COL18A1 expression that is highly expressed in recurrent NMIBC, suggesting that the stromal component of the tumor may play a crucial role in the recurrence process. Additionally, pseudotime trajectory analysis revealed a macrophage subtype with high IL-6 expression at the terminal stage of macrophage differentiation, exhibiting significant immunosuppressive features. This indicated the presence of immune exhaustion during NMIBC recurrence. Lastly, we found an upregulation of estrogen in recurrent urothelial cancer cells, which may partially explain the gender disparity observed in UBC.

conclusionThis study identified several cell subpopulations influencing NMIBC recurrence, which were heavily infiltrated in the TME of recurrent NMIBC. Additionally, the enrichment of estrogen in urothelial cancer cells from various sources suggested a role of sex hormones in NMIBC recurrence.

Indexed as

Neoplasm Recurrence, LocalSingle-Cell AnalysisTumor MicroenvironmentUrinary Bladder NeoplasmsAgedCancer-Associated FibroblastsFemaleGene Expression Regulation, NeoplasticHumansMaleMiddle AgedNon-Muscle Invasive Bladder NeoplasmsSequence Analysis, RNANon-muscle-invasive bladder cancerRecurrenceSex differencesSingle-cellTumor-associated fibroblastTumor-associated macrophages

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.